Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated

What Are Typical CK Levels During an Active IMNM Flare?

At a Glance

During an active IMNM flare, creatine kinase (CK) often rises into the thousands, commonly about 3,000 to above 10,000 U/L. A CK result alone cannot confirm a flare; clinicians also consider muscle strength, symptoms, kidney tests, and how the level changes over time.

Normal Creatine Kinase (CK) levels are often cited as being under 200 U/L, but “normal” ranges vary widely based on your sex, race, muscle mass, and the specific laboratory analyzing your blood [1]. You should always look at the specific reference range provided on your own lab report [1]. However, during an active flare of Immune-Mediated Necrotizing Myopathy (IMNM), CK levels are often markedly elevated [2]. It is common for these numbers to reach into the thousands, frequently ranging from 3,000 to over 10,000 U/L when the disease is highly active [2][3].

Understanding the Numbers

CK is an enzyme found inside your muscles. When muscle cells are injured or die—a process called necrosis, which is the primary hallmark of IMNM—large amounts of CK are released into the bloodstream. Studies of adult IMNM patients have found that the median peak CK level during an active disease phase is around 7,020 U/L [4]. Some individual cases in these studies have recorded peak values over 39,000 U/L or even 50,000 U/L [4][2], but it is important to remember that these represent extremes within study cohorts, not standard personal targets.

Your specific antibody subtype can also influence your lab results. Patients who test positive for specific IMNM antibodies—namely the anti-SRP or anti-HMGCR subtypes—tend to show higher baseline and flare CK numbers than those with seronegative IMNM (meaning no currently recognized myositis antibodies are detected) [3][2]. For example, in one study of patients with anti-HMGCR IMNM, average CK levels at diagnosis were nearly 8,000 U/L [3]. However, these ranges overlap significantly between groups, and your individual CK level does not determine your diagnosis or strictly predict your personal disease course.

Interpreting Your Results

Seeing CK numbers jump into the thousands can be concerning, but these high values are a recognized feature of active IMNM [2]. Keep in mind that a single elevated CK test does not automatically confirm a disease flare; CK can temporarily rise due to strenuous exercise, muscle injury, or certain medications [1].

As your immunosuppressant treatments begin to work and immune-mediated muscle injury settles, your CK levels will usually trend downward over time [5][6]. However, your CK level and your physical strength do not always align perfectly. Sometimes, CK levels can remain elevated even as your physical muscle strength improves [7]. Conversely, your CK might return to near-normal levels while you still feel profound weakness, because it takes significant time for damaged muscle tissue to rebuild itself. Your doctor will evaluate your physical strength, physical function, daily symptoms, and lab trends together to guide your care [7].

When to Seek Immediate Medical Attention

While elevated CK is expected in IMNM, massive and rapid muscle breakdown can lead to a dangerous complication called rhabdomyolysis [8]. When too much muscle protein (called myoglobin) floods into your bloodstream, it can cause severe, acute kidney injury [8][9].

Seek emergency medical care if you experience any of the following, as they could be signs of severe kidney or muscle injury:

  • Dark, tea-colored, or cola-colored urine [8]
  • A sudden, noticeable decrease in how much you urinate [10]
  • Rapidly worsening muscle weakness or severe, new muscle pain [9]
  • Confusion, vomiting, or sudden trouble breathing or swallowing

Common questions in this guide

What CK level is common during an active IMNM flare?
During active IMNM, CK often rises into the thousands, commonly around 3,000 to above 10,000 U/L. Studies have reported median peak levels near 7,020 U/L, but individual results can be much higher, and these values are not personal targets.
Does a high CK result prove that my IMNM is flaring?
No. A single high CK result does not confirm an IMNM flare because strenuous exercise, muscle injury, and some medications can also raise CK. Clinicians usually consider your muscle strength, physical function, symptoms, and CK trend together.
Can my CK improve before my muscle weakness does?
Yes. CK may remain elevated while strength improves, or it may return close to normal while weakness continues. Muscle tissue can take substantial time to rebuild after injury, so CK and strength do not always change at the same pace.
Why does IMNM cause very high CK levels?
CK is an enzyme stored inside muscle cells. When immune-mediated muscle injury causes cells to break down, CK is released into the bloodstream, which can produce markedly elevated results.
When is a high CK level during IMNM an emergency?
Seek emergency care for dark or cola-colored urine, much less urination, rapidly worsening weakness, severe new muscle pain, confusion, vomiting, or trouble breathing or swallowing. These symptoms can signal severe muscle breakdown, called rhabdomyolysis, and possible kidney injury.
Do anti-SRP or anti-HMGCR antibodies affect CK levels?
People with anti-SRP or anti-HMGCR IMNM often have higher CK levels at baseline and during flares than people with seronegative IMNM. The ranges overlap substantially, so an individual CK value does not establish the subtype or predict the entire disease course.
What other tests may be checked with CK in IMNM?
Your clinician may monitor kidney function and liver enzymes such as AST and ALT along with CK. The exact tests and schedule depend on your symptoms, treatment, and overall medical situation.

Get notified when new evidence is published on Immune-mediated necrotizing myopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Statin-Induced Necrotizing Autoimmune Myopathy: Diagnosis and Treatment Approach.

    Srinivasan V, Prabu S, Sfeir JG, Muthusamy K

    JCEM case reports 2024; (2(12)):luae227 doi:10.1210/jcemcr/luae227.

    PMID: 39659392
  2. 2

    Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series.

    Xiong A, Yang G, Song Z, et al.

    Therapeutic advances in neurological disorders 2021; (14()):1756286421998918 doi:10.1177/1756286421998918.

    PMID: 33786066
  3. 3

    Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.

    Tan E, Knight J, Khonasti S, et al.

    Internal medicine journal 2023; (53(10)):1846-1853 doi:10.1111/imj.16004.

    PMID: 36625419
  4. 4

    The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study.

    Khoo T, Tan E, Limaye V, et al.

    Rheumatology (Oxford, England) 2025; (64(9)):4995-5003 doi:10.1093/rheumatology/keaf238.

    PMID: 40347460
  5. 5

    Anti-HMGCR-Antibody-Positive Statin-Induced Myositis: A Pilot Case Series on Treatment with Bempedoic Acid and Immunosuppressive Therapy.

    Benucci M, Terenzi R, Li Gobbi F, et al.

    Antibodies (Basel, Switzerland) 2025; (14(3)) doi:10.3390/antib14030063.

    PMID: 40843675
  6. 6

    Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy.

    Yoon J, Kim SW, Kim SH, et al.

    Journal of clinical medicine 2025; (14(18)) doi:10.3390/jcm14186610.

    PMID: 41010829
  7. 7

    Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.

    Pinal-Fernandez I, Parks C, Werner JL, et al.

    Arthritis care & research 2017; (69(2)):263-270 doi:10.1002/acr.22920.

    PMID: 27111848
  8. 8

    Diagnostic Approach to Seronegative Autoimmune-Mediated Rhabdomyolysis: A Case Report.

    Behzadi C, Neavling N, Kurapati R

    Cureus 2026; (18(7)):e113239 doi:10.7759/cureus.113239.

    PMID: 42633337
  9. 9

    Severe Rhabdomyolysis in the Setting of Influenza A Infection and Clinically Suspected Anti-signal Recognition Particle-Positive Immune-Mediated Necrotizing Myopathy.

    Hoang YNN, Baral S

    Cureus 2026; (18(8)):e115167 doi:10.7759/cureus.115167.

    PMID: 42787800
  10. 10

    Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotising myopathy: a case report.

    Kodera T, Akiyama K, Kubota M, et al.

    Modern rheumatology case reports 2026; (10(1)) doi:10.1093/mrcr/rxag009.

    PMID: 41615001

This page explains CK results during an IMNM flare for informational purposes and does not constitute medical advice. Ask your treating clinician how to interpret your CK trend and when to seek urgent care.